Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Molecular and Cellular Biology|May 2, 2012
The tumor necrosis factor receptor stalk regions define responsiveness to soluble versus membrane-bound ligandChristine Richter, Sylvia Messerschmidt, Gerlinde Holeiter, et al.
Cancer Letters|September 11, 2017
TNF-related apoptosis-inducing ligand (TRAIL) for bone sarcoma treatment: Pre-clinical and clinical dataZakareya Gamie, Konstantinos Kapriniotis, Dimitra Papanikolaou, et al.
The American Journal of Pathology|April 25, 2012
The critical role of TAK1 in accentuated epithelial to mesenchymal transition in obliterative bronchiolitis after lung transplantationAaron Gardner, Andrew J Fisher, Christine Richter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2008
Single-chain TNF, a TNF derivative with enhanced stability and antitumoral activityAnja Krippner-Heidenreich, Ingo Grunwald, Gudrun Zimmermann, et al.
Cell Death & Disease|August 31, 2013
CLL cells are resistant to smac mimetics because of an inability to form a ripoptosome complexC Maas, J M Tromp, J van Laar, et al.
Cardiovascular Research|July 17, 2012
Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarctionJonathon Habersberger, Frederik Strang, Amelie Scheichl, et al.
Haematologica|March 7, 2020
Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemiaYuzhe Shi, Melanie C Beckett, Helen J Blair, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 1991
Interinstitutional experience in verification of external photon dose calculationsM E Masterson, G Barest, C S Chui, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
2-Ethoxybenzoxazole as a bioisosteric replacement of an ethyl benzoate group in a human rhinovirus (HRV) capsid binderRenee N Brown, Rachel Cameron, David K Chalmers, et al.
Diabetes Care|August 16, 2014
Efficacy and safety of oral methazolamide in patients with type 2 diabetes: a 24-week, placebo-controlled, double-blind studyRichard W Simpson, Geoffrey C Nicholson, Joseph Proietto, et al.
Pageof 12